Jing Fang Bai Du San was found to temporarily improve the clinical symptoms of patients, and network pharmacology analysis initially revealed that the targets of Jing Fang Bai Du San in the treatment of COVID-19 mainly included EGFR, PIK3CA, LCK, and MAPK1 [5]. The gene discussed is EGFR; the disease is COVID-19.